Tickertape - Financial freedom begins here
- NIFTY 5025,867.300.68% 173.60
- SENSEX84,065.750.58% 485.35
- MARKET MOOD14:20
Greed
Market and sectors
See All| NIFTY 100 Largecap | 26,481.800.70% | ||
| NIFTY 100 Midcap | 60,422.951.55% | ||
| NIFTY 100 Smallcap | 17,372.652.56% |
| NIFTY Bank | 60,668.150.91% | ||
| NIFTY IT | 35,592.750.05% | ||
| NIFTY Pharma | 22,321.201.64% |
| NIFTY 100 Largecap | 26,481.800.70% | ||
| NIFTY 100 Midcap | 60,422.951.55% | ||
| NIFTY 100 Smallcap | 17,372.652.56% |
| NIFTY Bank | 60,668.150.91% | ||
| NIFTY IT | 35,592.750.05% | ||
| NIFTY Pharma | 22,321.201.64% |
Today's stocks
| STOCKSPRICECHANGE | |
₹1,146.007.46%  | |
 Shriram Finance LtdSHRIRAMFIN | ₹1,062.706.00% |
₹124.415.34% | |
₹457.354.17% | |
₹11.584.14% |
Mutual funds and ETFs
| FUNDSRETURNS | |
 Equity • Growth | |
 12.19% Equity • Growth | |
 12.06% Equity • Growth | |
 11.39% Equity • Growth | |
 11.26% Equity • Growth | |
Curated screens and deals
_S5jGfVL3R.png)
_IftXKRDHL.png)
Market and sectors
See All| NIFTY 100 Largecap | 26,481.800.70% | ||
| NIFTY 100 Midcap | 60,422.951.55% | ||
| NIFTY 100 Smallcap | 17,372.652.56% |
| NIFTY Bank | 60,668.150.91% | ||
| NIFTY IT | 35,592.750.05% | ||
| NIFTY Pharma | 22,321.201.64% |
| NIFTY 100 Largecap | 26,481.800.70% | ||
| NIFTY 100 Midcap | 60,422.951.55% | ||
| NIFTY 100 Smallcap | 17,372.652.56% |
| NIFTY Bank | 60,668.150.91% | ||
| NIFTY IT | 35,592.750.05% | ||
| NIFTY Pharma | 22,321.201.64% |
Today's stocks
| STOCKSPRICECHANGE | |
₹1,146.007.46% | |
Shriram Finance LtdSHRIRAMFIN | ₹1,062.706.00% |
₹124.415.34% | |
₹457.354.17% | |
₹11.584.14% |
Curated screens and deals
PRIVISCLBoard of Privi Speciality Chemicals approves additional investment in Prigiv SpecialtiesThe board of Privi Speciality Chemicals at its meeting held on 09 February 2026 has approved an investment of an equity investment of Rs. 50 crore in Prigiv Specialties, a subsidiary company, to be made in the exiting shareholding ratio of 51:49. Accordingly, Privi shall invest 51% of the total equity investment, amounting to Rs. 25.5 core, and the balance 49% shall be contributed by its JV Partner, Givaudan SA. The infusion of equity capital will support its growth plans, thereby enabling the company to generate higher revenue and improved profitability going forward. Powered by Capital Market - Live
SURFI
TSFINV
HMTHMT announces appointment of Government Nominee DirectorHMT announced the appointment of Asit Gopal, SS&FA, Ministry of Heavy Industries (MHI) as Government Nominee Director on the Board of Directors of HMT with immediate effect Powered by Capital Market - Live
AUROPHARMAAurobindo Pharma board considers merger of subsidiariesThe board of Aurobindo Pharma at its meeting held on 09 February 2026 has approved a proposal to file a scheme of amalgamation for merger of Auro Vaccines, a wholly owned step-down subsidiary of the Company with Curateq Biologics, a wholly owned subsidiary of the Company, with Hon'ble NCLT, Hyderabad. Powered by Capital Market - Live
Ready-made PortfoliosInvestment Products
smallcaseMutual funds and ETFs
| FUNDSRETURNS | |
Equity • Growth | |
12.19% Equity • Growth | |
12.06% Equity • Growth | |
11.39% Equity • Growth | |
11.26% Equity • Growth | |
Money
Matters
- Assets tracked worth60,500 Cr
- Loved by60 L+ investors
- Downloads6.2M+
- Rated on Google Play4.2
